The Six Months of Kenton’s Biopharma Picks
Dr Alex Kenton supports LaDucTrading’s CLUB & EDGE members in his contributor Slack channel #kentons-corner-of-biopharma. He posts his insights on life sciences; analysis on healthcare; and biopharma stock research – as well as his trades. We take a look at his top picks over the last six months.
Breakthrough Biotech: $VKTX Changing The Game
A short clip from the interview on Weight Loss Pharmaceuticals In this short clip from the interview on Weight Loss Pharmaceuticals, Samantha LaDuc and Dr. Alex Kenton discuss the pharmaceutical company Viking Therapeutics and its drug development, specifically focusing on a drug for non-alcoholic steatohepatitis (NASH) that has completed phase two trials. They consider the […]
Breakthrough Biotech: $VKTX Changing The Game
A short clip from the interview on Weight Loss Pharmaceuticals In this short clip from the interview on Weight Loss Pharmaceuticals, Samantha LaDuc and Dr. Alex Kenton discuss the pharmaceutical company Viking Therapeutics and its drug development, specifically focusing on a drug for non-alcoholic steatohepatitis (NASH) that has completed phase two trials. They consider the […]
The Big Bang in Weight Loss Pharmaceuticals
Interview with Dr. Alex Kenton In this Exclusive Interview, Samantha LaDuc and Dr. Alex Kenton discuss the significant impact of weight loss drugs on the market, with a focus on biopharma. Dr. Kenton, a neonatologist with extensive experience in healthcare and biotech investing, shares his insights into the burgeoning weight loss drug sector, which he […]
The Big Bang in Weight Loss Pharmaceuticals
Interview with Dr. Alex Kenton In this Exclusive Interview, Samantha LaDuc and Dr. Alex Kenton discuss the significant impact of weight loss drugs on the market, with a focus on biopharma. Dr. Kenton, a neonatologist with extensive experience in healthcare and biotech investing, shares his insights into the burgeoning weight loss drug sector, which he […]
Crispr Therapeutics: Client Notes (January 25, 2024)
We are VERY lucky to have a ‘resident doctor’ in the house who is generous enough to share his insights and analysis with members. Alexander Kenton is a long-time EDGE member who actively trades and selectively holds biotech stocks – not exclusively but it is his ‘wheelhouse’ so tends to do most of his fishing there. As […]